Gerhardt Attard, Neeraj Agarwal, Julie N. Graff, Shahneen Sandhu, Eleni Efstathiou, Mustafa Özgüroğlu, Andrea J. Pereira de Santana Gomes, Karina Costa Maia Vianna, Hong Luo, Heather H. Cheng, Won Kim, Carly Rachel Varela, Daneen Schaeffer, Shiva Dibaj, Susan Li, Fei Shen, Suneel Dinkar Mundle, David Olmos, Kim N. Chi, Dana Rathkopf. "Phase 3 AMPLITUDE trial: Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) patients (pts) with alterations in homologous recombination repair (HRR) genes.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.17_suppl.lba5006